Status:
UNKNOWN
Dexmedetomidine on Prevention of Side Effects of Hemabate
Lead Sponsor:
Jin Ni
Conditions:
Gynecological Patient
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Hemabate is often used for gynecological patients. Hemabate is associated with many side effects, including a burning sensation in the stomach, nausea, vomiting, diarrhea etc. It is reported that dexm...
Eligibility Criteria
Inclusion
- gynecological patients
Exclusion
- Neuromuscular and endocrine diseases
- Allergic reactions to a2-adrenergic agonist
- Previous abdominal surgery including prior caesarean section.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02220361
Start Date
September 1 2014
End Date
December 1 2014
Last Update
September 30 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.